Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.3 was added and the previous Revision: v3.6.0 was removed. This indicates the page's version was updated.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRecruitment status is updated to indicate that no participants are being sought. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, along with a revision update from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check29 days agoChange DetectedRevision indicator updated from v3.5.4 to v3.5.5, signaling a small update to the page’s underlying version. This change reflects an internal patch or improvement rather than a modification to the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new page revision tag v3.5.4 is added, replacing v3.5.3, indicating an updated version of the study page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s displayed release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site/system update rather than a change to the study record content.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision number updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.